Loading...

AUPH AURINIA PHARMACEUTICALS INC Disposals and divestitures 8-K Filing

RN P

PH

AURINIA PHARMACEUTICALS INC

(AUPH)

2024 8-K

Merger Agreement Announced

Management Changes

Financial Results Report

Financial Results Update

Product Expansion

Financial Statements

Financial Results

Restructuring Announcement

Earnings Reports

Annual General Meeting of S...

Earnings Report

Departure of Executive Vice...

Financial Results, Program ...

Financial Results

Financial Results Announcement

Cooperation Agreement

New Directors Appointment

Earnings Report

Management Changes

AGM Voting Results

Earnings Reports

Positive Results from AUROR...

Confirmation of No Deposits...

Financial Results Announcement

Patent Allowance

Financial Results

Settlement Agreement

External Links:

Aurinia Pharmaceuticals Inc. announced its financial results for the quarter and year ended December 31, 2023, discontinuation of certain research and development programs, and authorization of a share repurchase program.

AI Assistant

AURINIA PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.